Skip Navigation LinksHome > May 2013 - Volume 8 - Issue 5 > Histology-Related Associations of ERCC1, RRM1, and TS Biomar...
Journal of Thoracic Oncology:
doi: 10.1097/JTO.0b013e318287c3c5
Original Articles

Histology-Related Associations of ERCC1, RRM1, and TS Biomarkers in Patients with Non–Small-Cell Lung Cancer: Implications for Therapy

Maus, Martin K.H. MD*†; Mack, Philip C. MD; Astrow, Stephanie H. PhD; Stephens, Craig L.; Zeger, Gary D. MD†§; Grimminger, Peter P. MD*; Hsiang, Jack H.; Huang, Eric PhD; Li, Tianhong PhD; Lara, Primo N. MD; Danenberg, Kathleen D.; Gandara, David R. MD

Collapse Box

Abstract

Introduction: On the basis of the results of recent clinical trials, histology-based decision-making for therapy of non–small-cell lung cancer has been advocated. We hypothesized associations of the biomarkers excision repair cross-complementing 1 (ERCC1), ribonucleotide reductase M1 (RRM1), and thymidylate synthase (TS) with histology as a contributing factor to reported differences in chemotherapy outcomes between squamous cell carcinoma (SCCA) and adenocarcinoma (AC) subtypes. Here, we report analysis of the Response Genetics Inc., database and implications for histology-based therapy.

Methods: RNA from microdissected formalin-fixed paraffin-embedded tumors was extracted and analyzed as previously described. Specimens from 2540 individual non–small-cell lung cancer patients were analyzed for one or more biomarkers, of which 1457 were categorized as AC or SCCA.

Results: For each biomarker, gene expression was lower in AC compared with SCCA (<0.001), although there was a wide range between individual patients. Gene expression was higher in men versus women: ERCC1: 2.51 versus 2.22 (p = 0.005); RRM1: 1.41 versus 1.24 (p = 0.004); TS: 3.23 versus 2.83 (p < 0.001). However, SCCA was more frequent in men versus women (30%/19%; p < 0.001). When AC and SCCA were assessed separately, the statistical significance between gene expression and sex was lost (in SCCA: ERCC1, p = 0.14; RRM1, p = 0.26; TS, p = 0.11).

Conclusions: This analysis represents the largest data set for gene expression of these biomarkers reported so far. Significant histology-related associations for ERCC1, RRM1, and TS are seen. However, marked heterogeneity exists in individual patient tumor expression levels. Randomized phase III trials assessing the predictive value of these chemotherapy-related biomarkers are warranted.

© 2013International Association for the Study of Lung Cancer

Login

Article Tools

Share

Search for Similar Articles
You may search for similar articles that contain these same keywords or you may modify the keyword list to augment your search.

Other Ways to Connect

Twitter
twitter.com/JTOonline

 



Visit JTO.org on your smartphone. Scan this code (QR reader app required) with your phone and be taken directly to the site.

 For additional oncology content, visit LWW Oncology Journals on Facebook.